Pacific Biosciences of California Inc (PACB) is down Thursday morning, with the stock losing -1.08% in pre-market trading to 3.68.
PACB's short-term technical score of 25 indicates that the stock has traded less bullishly over the last month than 75% of stocks on the market. In the Medical Devices industry, which ranks 118 out of 146 industries, PACB ranks higher than 37% of stocks.
Pacific Biosciences of California Inc has fallen 28.87% over the past month, closing at $5.53 on February 29. During this period of time, the stock fell as low as $3.52 and as high as $6.09. PACB has an average analyst recommendation of Strong Buy. The company has an average price target of $11.46.
PACB has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on PACB!
Pacific Biosciences of California Inc has a Long-Term Technical rank of 1. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 99% of the market scoring higher. In the Medical Devices industry which is number 115 by this metric, PACB ranks better than 115% of stocks.
